Latest research into retatritide peptide reveal promising outlook for treating obesity and type 2 diabetes. The compound, a dual stimulator of GLP-1 receptor and glucose-dependent insulinotropic polypeptide, appears to present greater weight reduction and glycemic control compared existing treatm